Trends in Buprenorphine Coverage and Prior Authorization Requirements in US Commercial Formularies, 2017-2021

ABSTRACT: This cross-sectional study assesses buprenorphine coverage and prior authorization requirements in US commercial formulary data from 2017 to 2021.

SUBMITTER: Nguyen T 

PROVIDER: S-EPMC9270692 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature